Alnylam Pharmaceuticals, Inc. (ALNY)
239.92
-0.77
(-0.32%)
USD |
NASDAQ |
Sep 01, 13:15
Alnylam Pharmaceuticals Net Income (TTM) : 807.99M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 807.99M |
| March 31, 2026 | 571.27M |
| December 31, 2025 | 347.02M |
| September 30, 2025 | 76.84M |
| June 30, 2025 | -285.81M |
| March 31, 2025 | -230.47M |
| December 31, 2024 | -278.16M |
| September 30, 2024 | -332.26M |
| June 30, 2024 | -72.94M |
| March 31, 2024 | -332.08M |
| December 31, 2023 | -440.24M |
| September 30, 2023 | -509.86M |
| June 30, 2023 | -1.064B |
| March 31, 2023 | -1.065B |
| December 31, 2022 | -1.131B |
| September 30, 2022 | -1.182B |
| June 30, 2022 | -980.72M |
| March 31, 2022 | -892.87M |
| December 31, 2021 | -852.82M |
| September 30, 2021 | -837.90M |
| June 30, 2021 | -886.68M |
| March 31, 2021 | -876.35M |
| December 31, 2020 | -858.28M |
| September 30, 2020 | -890.93M |
| June 30, 2020 | -846.17M |
| Date | Value |
|---|---|
| March 31, 2020 | -886.42M |
| December 31, 2019 | -886.12M |
| September 30, 2019 | -821.37M |
| June 30, 2019 | -858.12M |
| March 31, 2019 | -802.20M |
| December 31, 2018 | -761.50M |
| September 30, 2018 | -692.28M |
| June 30, 2018 | -569.94M |
| March 31, 2018 | -524.80M |
| December 31, 2017 | -490.87M |
| September 30, 2017 | -461.58M |
| June 30, 2017 | -442.72M |
| March 31, 2017 | -414.42M |
| December 31, 2016 | -410.11M |
| September 30, 2016 | -387.90M |
| June 30, 2016 | -360.62M |
| March 31, 2016 | -342.27M |
| December 31, 2015 | -290.07M |
| September 30, 2015 | -220.74M |
| June 30, 2015 | -187.94M |
| March 31, 2015 | -160.23M |
| December 31, 2014 | -360.40M |
| September 30, 2014 | -371.36M |
| June 30, 2014 | -357.06M |
| March 31, 2014 | -331.16M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | -564.78M |
| BridgeBio Pharma, Inc. | -702.02M |
| Regeneron Pharmaceuticals, Inc. | 4.329B |
| Vertex Pharmaceuticals, Inc. | 4.405B |
| Pfizer Inc. | 4.373B |